Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs.
Saved in:
| Title: | Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs. |
|---|---|
| Authors: | Andrews HS; Friends of Cancer Research, Washington, DC, 20036, United States., Agnihotram R; Johnson and Johnson Innovative Medicines, Raritan, NJ, 08869, United States., Blumenthal G; Pfizer, Inc, New York, NY, 10001, United States., Bullock J; GSK, Philadelphia , PA, 19112, United States., Collins G; Friends of Cancer Research, Washington, DC, 20036, United States., Doherty GJ; AstraZeneca, Cambridge, United Kingdom., Farago AF; Amgen, Inc, Thousand Oaks, CA, 91320, United States., Ishii Y; Independent Patient Advocate, Washington, DC, 20036, United States., Kasichayanula S; Gilead Sciences., Inc, Forester City, CA, 94404, United States., LeBlanc M; Fred Hutchinson Cancer Center, Seattle, WA, 98109, United States., Levi-D'Ancona E; Friends of Cancer Research, Washington, DC, 20036, United States., Li C; Genentech, Inc, San Francisco, CA, 94080, United States., McCullough K; GSK, Philadelphia , PA, 19112, United States., Morrow PKP; Takeda Pharmaceuticals, Inc, Cambridge, MA, 02142, United States., Navarro B; Friends of Cancer Research, Washington, DC, 20036, United States., Sandhu P; Daiichi Sankyo, Basking Ridge, NJ, 07920, United States., Shah S; Johnson and Johnson Innovative Medicines, Raritan, NJ, 08869, United States., Sharon E; Dana-Farber Cancer Institute, Boston, MA, 02215, United States., Su Z; Marengo Therapeutics, Cambridge, MA, 02139, United States., Vallett C; Independent Patient Advocate, Washington, DC, 20036, United States., Villalobos Y; Eli Lilly and Company, Indianapolis, IN, 46285, United States., Allen JD; Friends of Cancer Research, Washington, DC, 20036, United States., Stewart MD; Friends of Cancer Research, Washington, DC, 20036, United States. |
| Source: | The oncologist [Oncologist] 2026 Jun 06; Vol. 31 (7). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyag222 |
